Therapy Cells announces a new license granted to Contravaccine Ltd. This license enables Contravaccine to grow a line of granulosa cells for use in NON-Surgical sterilisation of Cats and Dogs! This joint venture is in final clinical testing with access to the existing $650 Million/Annum North American spey market. Royalties to flow to Therapy Cells by December 2014. More news to follow!
Market Data 
Markets 
AI
